initial public offerings (IPOs) trading on American exchanges
Showing posts with label GFS. Show all posts
Showing posts with label GFS. Show all posts

Friday, February 11, 2022

GlobalFoundries (GFS) began trading on the Nasdaq on Thur 28 Oct 21

GlobalFoundries, which was spun off from Advanced Micro Devices (AMD) in 2009, is the world’s third-largest foundry based on revenue. In 2020, the company reported revenue of $5.7 billion. As demand for chips surged in 2021, GlobalFoundries’ net revenue for the first half of the year was $3.04 billion, an increase of about 13% from a year earlier. Some of the company’s largest customers include several Nasdaq-listed companies, such as Qualcomm (QCOM), NXP Semiconductors (NXPI), AMD and Broadcom (AVGO).

GlobalFoundries Inc. is a multinational semiconductor contract manufacturing and design company incorporated in the Cayman Islands and headquartered in Malta, New York. 
Headquarters: Santa Clara, CA
CEO: Thomas Caulfield (Mar 9, 2018–)
Revenue: 6 billion USD (2020)
Number of employees: 15,000
Founded: March 2, 2009, Sunnyvale, CA
  • IPO date: Oct. 28 
  • Nasdaq’s largest U.S. IPO by proceeds raised in 2021 and the largest semiconductor IPO in its history.

Monday, November 22, 2021

IPOs this week : Nov. 22 - 26, 21 (wk 47)

IPO quiet period expirations
  • Globalfoundries (NASDAQ:GFS), Fluence Energy (NASDAQ:FLNC), Informatica (NYSE:INFA), Rent the Runway (NASDAQ:RENT), Solo Brands (NYSE:DTC), Arteris (NASDAQ:AIP), Augmedix (NASDAQ:AUGX) and Marpai (NASDAQ:MRAI) on November 22. 
  • HireRight (NYSE:HRT), Udemy (NASDAQ:UDMY), Entrada Therapeutics (NASDAQ:TRDA), Sonendo (NYSE:SONX), AirSculpt Technologies (NASDAQ:AIRS), Aura Biosciences (NASDAQ:AURA), Biofrontera (NASDAQ:BFRI) on November 23.
IPO lockup expirations
  • Paymentus (PAY) on November 22, 
  • Figs (NYSE:FIGS), Singular Genomics Systems (NASDAQ:OMIC) and Day One Biopharmaceuticals (NASDAQ:DAWN) on November 23. 
  • Centessa Pharmaceuticals (NASDAQ:CNTA) and Zivo Bioscience (NASDAQ:ZIVO) see IPO lockup periods end on November 24 and LianBio (NASDAQ:LIAN) has its lockup period expiring on November 26.